Mike Brennan has been investing in the healthcare industry as a member of the Water Street team since 2007. As a principal, Mike identifies and executes new investments, and assists with the strategic management of our group of healthcare companies. Mike currently serves on the boards of directors of Cato-SMS Research, Discovery Life Sciences and EVERSANA. Prior to joining Water Street, Mike worked in the Investment Banking Group of Deutsche Bank Securities. He earned a bachelor’s degree in accountancy from the University of Illinois at Urbana-Champaign and a master’s in business administration from Northwestern University’s Kellogg School of Management.